liposomal glutathione vs standard oral bioavailability The benefits of supplementation | Formulations liposomal vs standard oral glutathione

Kim, M.-H., & Kim, H

doi: 10.1053/j.gastro.2012.05.049

HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use

, , ,

This article is for educational and informational purposes only, and is based on published scientific literature